MedifastFRA:MDF +3.59%69 Return-on-Tangible-Equity is -4.31% as of Mar. 2026. GuruFocus rates FRA:MDF with a GF Score™ of 69/100 and a GF Value™ of €7.00 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 87 Personal Services companies, Medifast ranks worse than 88.51% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medifast's annualized net income for the quarter that ended in Mar. 2026 was €-7.3 Mil. Medifast's average shareholder tangible equity for the quarter that ended in Mar. 2026 was €170.4 Mil. Therefore, Medifast's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -4.31%.
The historical rank and industry rank for Medifast's Return-on-Tangible-Equity or its related term are showing as below:
FRA:MDF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -9.64 Med: 53.52 Max: 91.2
Current: -9.64
During the past 13 years, Medifast's highest Return-on-Tangible-Equity was 91.20%. The lowest was -9.64%. And the median was 53.52%.
FRA:MDF's Return-on-Tangible-Equity is ranked worse than 88.51% of 87
companies
in the Personal Services industry
Industry Median: 12.91
vs FRA:MDF: -9.64
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Medifast Return-on-Tangible-Equity Related Terms
Medifast Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Medifast's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MDF vs RGS, EVTK, DROR: Return-on-Tangible-Equity Comparison
For the Personal Services subindustry, Medifast's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast Return-on-Tangible-Equity vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Medifast's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -4.31% mean?
Medifast (FRA:MDF) has a Return-on-Tangible-Equity of -4.31% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medifast and its competitors. According to the industry distribution chart, Medifast ranks #77 out of 87 companies in the Personal Services industry, placing it in the top 88.5%.
Is Medifast's Return-on-Tangible-Equity too high?
Medifast's current Return-on-Tangible-Equity is -4.31%. Based on the distribution chart, Medifast ranks #77 out of 87 companies in the Personal Services industry, which is in the bottom quartile relative to peers. Overall, Medifast has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Return-on-Tangible-Equity compare to RGS and EVTK?
According to the Personal Services industry distribution chart, Medifast ranks #77 out of 87 companies for Return-on-Tangible-Equity. This places Medifast in the lower half of its industry. The industry median Return-on-Tangible-Equity is 12.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Personal Services company?
The median Return-on-Tangible-Equity among Personal Services companies is 12.91, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medifast and its competitors. For the Personal Services industry, the median Return-on-Tangible-Equity is 12.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current Return-on-Tangible-Equity is -4.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.00, compared to a current price of €9.24 — trading 32% above its estimated fair value. The current Return-on-Tangible-Equity is -4.31%. Medifast's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Medifast (FRA:MDF), the current Return-on-Tangible-Equity is -4.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (FRA:MDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of €9.24 is trading 32% above its estimated GF Value™ of €7.00.
GuruFocus considers Medifast to be Significantly Overvalued.
Key valuation signals for FRA:MDF:
Return-on-Tangible-Equity: -4.31%
GF Value™: €7.00 vs. price of €9.24 (32% above fair value)
No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score
Get the complete analysis for FRA:MDF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MDF has been successfully added to your 
